Hjem
Siv Lise Bedringaass bilde

Siv Lise Bedringaas

Overingeniør
  • E-postSiv.Bedringaas@uib.no
  • Telefon+47 55 97 30 59+47 454 95 691
  • Besøksadresse
    Laboratoriebygget
    Bergen
    Rom 
    3160
  • Postadresse
    Postboks 7804
    5020 Bergen

Tilknyttet Forskningsgruppe for Presisjonsonkologi, CCBio

HMS-koordinator ved K2

Vitenskapelig artikkel
  • Forthun, Rakel Brendsdal; Aasebø, Elise; Rasinger, Josef Daiel; Bedringaas, Siv Lise; Berven, Frode; Selheim, Frode; Bruserud, Øystein; Gjertsen, Bjørn Tore. 2017. Phosphoprotein DIGE profiles reflect blast differentiation, cytogenetic risk stratification, FLT3/NPM1 mutations and therapy response in acute myeloid leukaemia. Journal of Proteomics. 32-41.
  • Sandtorv, Alexander Harald; Leitch, Calum; Bedringaas, Siv Lise; Gjertsen, Bjørn Tore; Bjørsvik, Hans-Rene. 2015. 4-alkylated silver-N-heterocyclic carbene (NHC) complexes with cytotoxic effects in leukemia cells. ChemMedChem. 1522-1527.
  • Hatfield, Kimberley Joanne; Bedringaas, Siv Lise; Ryningen, Anita; Gjertsen, Bjørn Tore; Bruserud, Øystein. 2010. Hypoxia increases HIF-1 alpha expression and constitutive cytokine release by primary human acute myeloid leukaemia cells. European Cytokine Network. 154-164.
  • Sjøholt, Gry; Bedringaas, Siv Lise; Døskeland, Anne Paulus; Gjertsen, Bjørn Tore. 2006. Proteomic strategies for individualizing therapy of acute myeloid leukemia (AML). Current Pharmaceutical Biotechnology. 159-170.
Hovedfagsoppgave
  • Bedringaas, Siv Lise. 1992. Tranfeksjon av den humane thyrocyt cellelinjen SGHTL-34 med oncogener og optimalisering av tranfeksjonsbetingelser.
Sammendrag/abstract
  • Hatfield, Kimberley Joanne; Bedringaas, Siv Lise; Gjertsen, Bjørn Tore; Bruserud, Øystein. 2010. OXYGEN LEVELS INFLUENCE THE CYTOKINE RELEASE PROFILE OF AML CELLS. Experimental Hematology. S119-S119.
  • Wergeland, Line; Oveland, Eystein; Sjøholt, Gry; Bedringaas, Siv Lise; Hovland, Randi; Bruserud, Øystein; Gjertsen, Bjørn Tore. 2008. FLT3 internal tandem duplication involving its libiquitin dependent endocytosis motif suspend modulation by HDM2 and are associated with inferior survival in AML. Haematologica. 10-10.
  • Wergeland, Line; Oveland, Eystein; Sjøholt, Gry; Bedringaas, Siv Lise; Hovland, Randi; Bruserud, Øystein; Gjertsen, Bjørn Tore. 2007. Flt3 mutations in proximity to an ubiquitin dependent endocytosis motif suspend its Hdm2 modulation. Blood. 148B-148B.
  • Parlati, Francesco; Aujay, Monette; Bedringaas, Siv Lise; Demo, Susan; Gjertsen, Bjørn Tore; Goldstein, Eileen; Jiang, Jing; Kirk, Christopher; Laidig, Guy; Lorens, James; Lu, Yan; Micklem, David Robert; Ruurs, Paulina; Shenk, Kevin; Sylvain, Catherine; Sun, Congcong; Woo, Tina; Zhou, Han-Jie; Bennett, Mark. 2007. Anti-tumor activity of immunoproteasome selective inhibitors. Blood. 477A-478A.
Poster
  • Lundevall, Frida Johanne; Bedringaas, Siv Lise; Törnroos, Karl Wilhelm; Gjertsen, Bjørn Tore; Bjørsvik, Hans-René. 2019. Synthesis and investigation of Ag-NHC complexes with cytotoxic properties towards cell lines modelling acute myeloid leukemia .
  • Wergeland, Line; Oveland, Eystein; Sjøholt, Gry; Bedringaas, Siv Lise; Hovland, R; Bruserud, Øystein; Gjertsen, Bjørn Tore. 2007. Flt3 Mutations in Proximity to an Ubiquitin Dependent Endocytosis Motif Suspend Its Hdm2 Modulation.
  • Parlati, F; Aujay, M; Bedringaas, Siv Lise; Demo, S; Gjertsen, Bjørn Tore; Goldstein, E; Jiang, J; Kirk, C; Laidig, G; Lorens, James; Lu, YS; Micklem, David Robert; Ruurs, Paulina; Shenk, K; Sylvain, C; Congcong, Sun C; Woo, T; Xhou, H-J; Bennet, M. 2007. Anti-Tumor Activity of Immunoproteasome Selective Inhibitors.
Vitenskapelig oversiktsartikkel/review
  • Sjøholt, Gry; Bedringaas, Siv Lise; Døskeland, Anne Paulus; Gjertsen, Bjørn Tore. 2006. Proteomic strategies for individualizing therapy of acute myeloid leukemia (AML). 159-170.

Se fullstendig oversikt over publikasjoner i CRIStin.